NT-pro BNPNT pro-BNPhypertrophic cardiomyopathyHCMhypertrophic cardiomyopathyAbstract
…stract 1-029 Figure 1Correlation of maximal wall thickness with NT-pro BNP in patients with pathogenic gene mutations for hypertrophic car…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…stract 1-029 Figure 1Correlation of maximal wall thickness with NT-pro BNP in patients with pathogenic gene mutations for hypertrophic car…
…ic therapies designed to target the underlying pathophysiology. Mavacamten, a first-in-class cardiac myosin inhibitor, received approval i…